首页> 外国专利> Pharmaceutical composition for preventing or treating ischemic-reperfusion injury comprising bile acids

Pharmaceutical composition for preventing or treating ischemic-reperfusion injury comprising bile acids

机译:用于预防或治疗缺血再灌注损伤的药物组合物包含胆汁酸

摘要

The present invention relates to a composition for preventing, treating, or alleviating ischemia-reperfusion injury, containing bile acid. According to the present invention, bile acid increases intranuclear beta-catenin levels, interferes with the opening of a mitochondria permeable transition pore (mPTP), and has excellent effects, in ischemia-reperfusion injury animal models, of alleviating tissue injury and reducing the size of infarcts, thereby being usable in the prevention, treatment, or alleviation of ischemia-reperfusion injury.
机译:本发明涉及用于预防,治疗或减轻含胆汁酸的缺血再灌注损伤的组合物。 根据本发明,胆汁酸增加核内β-连环蛋白水平,干扰线粒体渗透过渡孔(MPTP)的开口,并且在缺血再灌注损伤动物模型中具有优异的效果,可以减轻组织损伤并减小尺寸 梗死,从而可用于预防,治疗或减轻缺血再灌注损伤。

著录项

  • 公开/公告号US11185553B2

    专利类型

  • 公开/公告日2021-11-30

    原文格式PDF

  • 申请/专利权人 SAMSUNG LIFE PUBLIC WELFARE FOUNDATION;

    申请/专利号US201716345483

  • 发明设计人 HYEON CHEOL GWON;HYUNG SUK JANG;

    申请日2017-10-31

  • 分类号A61K31/575;A61P9/10;A23L33/10;A23L29;

  • 国家 US

  • 入库时间 2022-08-24 22:16:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号